Form D · Pharmaceuticals
Companion Spine, LLC
New York, NY · CIK 0002002037
Offering snapshot reported Feb 14, 2024 · SEC filing
- Reported sold
- $8.5M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 2, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2024 | Initial | $8,500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-505191
283,105 warrants were issued at an exercise price of $2.8258
Source: Form D, filed Feb 14, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anthony G Viscogliosi | Director, Executive |
| John Viscogliosi | Director |
| Marc R Viscogliosi | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
505 Park Ave. 14 Th Floor
New York, NY, 10022
New York, NY, 10022